D-AMINO ACID OXIDASE: A REVIEW
Abstract
ABSTRACT
Over many years, D-serine and glycine were found to be the endogenous ligands for glycine-binding site for N-methyl-D-aspartate receptors. D-serine
before being used up by the cells undergoes oxidative deamination by the enzyme D-amino acid oxidase (DAAO) and makes D-serine levels reduced in
the brain, thereby affecting brain functions. In this review, we will discuss about the synthesis, location, therapeutic potential of DAAO function, role
in cognition, and neuropathic pain.
Keywords: D-serine, Glycine, N-methyl-D-aspartate receptors, D-amino acid oxidase, Cognition, Neuropathy.
Downloads
References
REFERENCES
Sason H, Billard JM, Smith GP, Safory H, Neame S, Kaplan E, et al.
Asc-1 transporter regulation of synaptic activity via the tonic release of
d-serine in the forebrain. Cereb Cortex 2016. pii: Bhv350.
Nilsson A, Duan J, Mo-Boquist LL, Benedikz E, Sundström E.
Characterisation of the human NMDA receptor subunit NR3A glycine
binding site. Neuropharmacology 2007;52(4):1151-9.
Supplisson S, Bergman C. Control of NMDA receptor activation by
a glycine transporter co-expressed in Xenopus oocytes. J Neurosci
;17(12):4580-90.
Wood PL. The NMDA receptor complex: A long and winding road to
therapeutics. IDrugs;8(3):229-35.
Ivanovic A, Reiländer H, Laube B, Kuhse J. Expression and initial
characterization of a soluble glycine binding domain of the N-methylD-aspartate
receptor
NR1 subunit. J
Biol
Chem 1998;273(32):19933-7.
O’Shea RD, Manallack DT, Conway EL, Mercer LD, Beart PM.
Evidence for heterogeneous glycine domains but conserved multiple
states of the excitatory amino acid recognition site of the NMDA
receptor: Regional binding studies with [3H]glycine and [3H]
L-glutamate. Exp Brain Res 1991;86(3):652-62.
Ransom RW, Deschenes NL. Polyamines regulate glycine interaction
with the N-methyl-D-aspartate receptor. Synapse 1990;5(4):294-8.
Liu ZQ, Gu XH, Yang YJ, Yin XP, Xu LJ, Wang W. D-Serine in the
nucleus accumbens region modulates behavioral sensitization and
extinction of conditioned place preference. Pharmacol Biochem Behav
;143:44-56.
Yu H, Li T, Cui Y, Liao Y, Wang G, Gao L, et al. Effects of lead
exposure on D-serine metabolism in the hippocampus of mice at the
early developmental stages. Toxicology 2014;325:189-99.
Scianni M, Antonilli L, Chece G, Cristalli G, Di Castro MA, Limatola C,
et al. Fractalkine (CX3CL1) enhances hippocampal N-methyl-Daspartate
receptor
(NMDAR)
function
via
D-serine
and
adenosine
receptor
type
A2
(A2AR) activity.
J
Neuroinflammation
;10:108.
Dieb W, Hafidi A. Astrocytes are involved in trigeminal dynamic
mechanical allodynia: Potential role of D-serine. J Dent Res
;92(9):808-13.
Chung SP, Sogabe K, Park HK, Song Y, Ono K, Abou El-Magd RM, et al.
Potential cytotoxic effect of hydroxypyruvate produced from D-serine
by astroglial D-amino acid oxidase. J Biochem 2010;148(6):743-53.
Suzuki C, Murakami M, Yokobori H, Tanaka H, Ishida T, Horiike K,
et al. Rapid determination of free D-serine with chicken D-serine
dehydratase. J Chromatogr B Analyt Technol Biomed Life Sci
;879(29):3326-30.
Bharath SR, Bisht S, Savithri HS, Murthy MR. Crystal structures
of open and closed forms of d-serine deaminase from Salmonella
typhimurium - Implications on substrate specificity and catalysis.
FEBS J 2011;278(16):2879-91.
El Sayed SM, Abou El-Magd RM, Shishido Y, Chung SP, Sakai T,
Watanabe H, et al. D-amino acid oxidase gene therapy sensitizes
glioma cells to the antiglycolytic effect of 3-bromopyruvate. Cancer
Gene Ther 2012;19(1):1-18.
Ito T, Takahashi K, Naka T, Hemmi H, Yoshimura T. Enzymatic assay
of D-serine using D-serine dehydratase from Saccharomyces cerevisiae.
Anal Biochem 2007;371(2):167-72.
Gholizadeh A, Kohnehrouz BB. Molecular cloning and expression in
Escherichia coli of an active fused Zea mays L. D-amino acid oxidase.
Biochemistry (Mosc) 2009;74(2):137-44.
Horio M, Kohno M, Fujita Y, Ishima T, Inoue R, Mori H, et al. Levels
of D-serine in the brain and peripheral organs of serine racemase (Srr)
knock-out mice. Neurochem Int 2011;59(6):853-9.
Xin YF, Zhou XJ, Cheng X, Wang YX. Renal D-amino acid oxidase
mediates chiral inversion of N(G)-nitro-D-arginine. J Pharmacol Exp
Ther 2005;312(3):1090-6.
Mujawar SK. D-amino acid oxidase: Its potential in the production
of 7-aminocephalosporanic acid. Hindustan Antibiot Bull
;41(1-4):1-14.
Zhang H, Qi L, Lin Y, Mao L, Chen Y. Study on the decrease of
renal D-amino acid oxidase activity in the rat after renal ischemia
by chiral ligand exchange capillary electrophoresis. Amino Acids
;42(1):337-45.
Sasaki T, Kinoshita Y, Matsui S, Kakuta S, Yokota-Hashimoto H,
Kinoshita K, et al. N-methyl-d-aspartate receptor coagonist d-serine
suppresses intake of high-preference food. Am J Physiol Regul Integr
Comp Physiol 2015;309(5):R561-75.
Luykx JJ, Bakker SC, Visser WF, Verhoeven-Duif N, Buizer-
Asian J Pharm Clin Res, Vol 9, Issue 4, 2016, 33-36
Nithya and Shanmugarajan
Voskamp JE, den Heijer JM, et al. Genome-wide association study of
NMDA receptor coagonists in human cerebrospinal fluid and plasma.
Mol Psychiatry 2015;20(12):1557-64.
Le Bail M, Martineau M, Sacchi S, Yatsenko N, Radzishevsky I,
Conrod S, et al. Identity of the NMDA receptor coagonist is synapse
specific and developmentally regulated in the hippocampus. Proc Natl
Acad Sci USA 2015;112(2):E204-13.
Balu DT, Coyle JT. Chronic D-serine reverses arc expression and
partially rescues dendritic abnormalities in a mouse model of NMDA
receptor hypofunction. Neurochem Int 2014;75:76-8.
Rozsa E, Vigh J. Glycine transporter 1 modulates GABA release from
amacrine cells by controlling occupancy of coagonist binding site of
NMDA receptors. J Neurophysiol 2013;110(6):1393-403.
Brouwer A, Luykx JJ, van Boxmeer L, Bakker SC, Kahn RS. NMDAreceptor
coagonists
in serum,
plasma,
and cerebrospinal
fluid
of
schizophrenia
patients:
A
meta-analysis
of
case-control studies.
Neurosci
Biobehav Rev 2013;37(8):1587-96.
Luykx JJ, Bakker SC, van Boxmeer L, Vinkers CH, Smeenk HE,
Visser WF, et al. D-amino acid aberrations in cerebrospinal fluid and
plasma of smokers. Neuropsychopharmacology 2013;38(10):2019-26.
Clarke RJ, Glasgow NG, Johnson JW. Mechanistic and structural
determinants of NMDA receptor voltage-dependent gating and slow
Mg2 unblock. J Neurosci 2013;33(9):4140-50.
Barbaro E, Zangrando R, Vecchiato M, Turetta C, Barbante C,
Gambaro A. D- and L-amino acids in Antarctic lakes: Assessment
of a very sensitive HPLC-MS method. Anal Bioanal Chem
;406(22):5259-70.
Wang Y, Lu WQ, Li DF, Liu XT, Wang HL, Niu S, et al. Energy and ileal
digestible amino Acid concentrations for growing pigs and performance
of weanling pigs fed fermented or conventional soybean meal. AsianAustralas
J Anim
Sci 2014;27(5):706-16.
Min Q, Zhang X, Chen X, Li S, Zhu JJ. N-doped graphene: An alternative
carbon-based matrix for highly efficient detection of small molecules
by negative ion MALDI-TOF MS. Anal Chem 2014;86(18):9122-30.
Broderick GA, Faciola AP, Armentano LE. Replacing dietary soybean
meal with canola meal improves production and efficiency of lactating
dairy cows. J Dairy Sci 2015;98(8):5672-87.
Hellwig M, Bunzel D, Huch M, Franz CM, Kulling SE, Henle T, et al.
Stability of individual maillard reaction products in the presence of the
human colonic microbiota. J Agric Food Chem 2015;63(30):6723-30.
Suárez LM, Muñoz MD, MartÃn Del RÃo R, SolÃs JM. Taurine content
in different brain structures during ageing: Effect on hippocampal
synaptic plasticity. Amino Acids 2016;48:1199-208.
Wu HF, Yen HJ, Huang CC, Lee YC, Wu SZ, Lee TS, et al. Soluble
epoxide hydrolase inhibitor enhances synaptic neurotransmission and
plasticity in mouse prefrontal cortex. J Biomed Sci 2015;22:94.
Bencsik N, SzÃber Z, Liliom H, Tárnok K, Borbély S, Gulyás M, et al.
Protein kinase D promotes plasticity-induced F-actin stabilization
in dendritic spines and regulates memory formation. J Cell Biol
;210(5):771-83.
Lu W, Ai H, Peng L, Wang JJ, Zhang B, Liu X, et al. A novel
phosphorylation site of N-methyl-D-aspartate receptor GluN2B
at S1284 is regulated by Cdk5 in neuronal ischemia. Exp Neurol
;271:251-8.
Han H, Peng Y, Dong Z. D-Serine rescues the deficits of hippocampal
long-term potentiation and learning and memory induced by sodium
fluoroacetate. Pharmacol Biochem Behav 2015;133:51-6.
Ohgi Y, Futamura T, Hashimoto K. Glutamate signaling in
synaptogenesis and NMDA Receptors as potential therapeutic targets
for psychiatric disorders. Curr Mol Med 2015;15(3):206-21.
Madeira C, Lourenco MV, Vargas-Lopes C, Suemoto CK, Brandão CO,
Reis T, et al. d-serine levels in Alzheimer’s disease: Implications for
novel biomarker development. Transl Psychiatry 2015;5:e561.
Wang XQ, Zhong XL, Li ZB, Wang HT, Zhang J, Li F, et al. Differential
roles of hippocampal glutamatergic receptors in neuropathic anxietylike
behavior
after
partial
sciatic
nerve
ligation
in
rats.
BMC
Neurosci
;16:14.
Ishiwata S, Umino A, Balu DT, Coyle JT, Nishikawa T. Neuronal serine
racemase regulates extracellular D-serine levels in the adult mouse
hippocampus. J Neural Transm (Vienna) 2015;122(8):1099-103.
Matsuura A, Fujita Y, Iyo M, Hashimoto K. Effects of sodium benzoate
on pre-pulse inhibition deficits and hyperlocomotion in mice after
administration of phencyclidine. Acta Neuropsychiatr 2015;27(3):159-67.
Kolodney G, Dumin E, Safory H, Rosenberg D, Mori H, Radzishevisky I,
et al. Nuclear compartmentalization of serine racemase regulates
d-serine production: Implications for N-methyl-d-aspartate (NMDA)
receptor activation. J Biol Chem 2015;290(52):31037-50.
Lefèvre Y, Amadio A, Vincent P, Descheemaeker A, Oliet SH, Dallel R,
et al. Neuropathic pain depends upon D-serine co-activation of spinal
NMDA receptors in rats. Neurosci Lett 2015;603:42-7.
Nitoker N, Major DT. Understanding the reaction mechanism
and intermediate stabilization in mammalian serine racemase
using multiscale quantum-classical simulations. Biochemistry
;54(2):516-27.
Odemis S, Tuzun E, Gulec H, Semiz UB, Dasdemir S, Kucuk M, et al.
Association between polymorphisms of DNA repair genes and risk of
schizophrenia. Genet Test Mol Biomarkers 2016;20(1):11-7.
de Bartolomeis A, Errico F, Aceto G, Tomasetti C, Usiello A, Iasevoli F.
D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidineinduced
gene
expression
changes of
postsynaptic density
molecules
in
cortex and
striatum. Prog
Neuropsychopharmacol Biol
Psychiatry
;62:35-43.
Van Horn MR, Sild M, Ruthazer ES. D-serine as a gliotransmitter
and its roles in brain development and disease. Front Cell Neurosci
;7:39.
Ju P, Cui D. The involvement of N-methyl-d-aspartate receptor
(NMDAR) subunit NR1 in the pathophysiology of schizophrenia. Acta
Biochim Biophys Sin (Shanghai) 2016;48(3):209-19.
Hardingham GE, Do KQ. Linking early-life NMDAR hypofunction
and oxidative stress in schizophrenia pathogenesis. Nat Rev Neurosci
;17(2):125-34.
Kumar A. NMDA receptor function during senescence: Implication on
cognitive performance. Front Neurosci 2015;9:473.
Sapkota K, Mao Z, Synowicki P, Lieber D, Liu M, Ikezu T, et al. GluN2D
N-methyl-d-aspartate receptor subunit contribution to the stimulation
of brain activity and gamma oscillations by ketamine: Implications for
schizophrenia. J Pharmacol Exp Ther 2016;356(3):702-11.
Howitt J, Low LH, Putz U, Doan A, Lackovic J, Goh CP, et al. Ndfip1
represses cell proliferation by controlling Pten localization and
signaling specificity. J Mol Cell Biol 2015;7(2):119-31.
Chen LL, Song JX, Lu JH, Yuan ZW, Liu LF, Durairajan SS, et al.
Corynoxine, a natural autophagy enhancer, promotes the clearance of
alpha-synuclein via Akt/mTOR pathway. J Neuroimmune Pharmacol
;9(3):380-7.
Sayano T, Kawakami Y, Kusada W, Suzuki T, Kawano Y, Watanabe
A, et al. L-serine deficiency caused by genetic Phgdh deletion
leads to robust induction of 4E-BP1 and subsequent repression of
translation initiation in the developing central nervous system. FEBS J
;280(6):1502-17.
Lin CH, Chen PK, Chang YC, Chuo LJ, Chen YS, Tsai GE, et al.
Benzoate, a D-amino acid oxidase inhibitor, for the treatment of
early-phase Alzheimer disease: A randomized, double-blind, placebocontrolled
trial. Biol Psychiatry 2014;75(9):678-85.
Caldinelli L, Sacchi S, Molla G, Nardini M, Pollegioni L. Characterization
of human DAAO variants potentially related to an increased risk of
schizophrenia. Biochim Biophys Acta 2013;1832(3):400-10.
Nagai T, Yu J, Kitahara Y, Nabeshima T, Yamada K. D-serine ameliorates
neonatal PolyI: C treatment-induced emotional and cognitive
impairments in adult mice. J Pharmacol Sci 2012;120(3):213-27.
Donzis EJ, Thompson LT. D-cycloserine enhances both intrinsic
excitability of CA1 hippocampal neurons and expression of activityregulated
cytoskeletal (Arc) protein. Neurosci Lett 2014;571:50-4.
Coultrap SJ, Freund RK, O’Leary H, Sanderson JL, Roche KW,
Dell’Acqua ML, et al. Autonomous CaMKII mediates both LTP and
LTD using a mechanism for differential substrate site selection. Cell
Rep 2014;6(3):431-7.
Rendeiro C, Foley A, Lau VC, Ring R, Rodriguez-Mateos A, Vauzour D,
et al. A role for hippocampal PSA-NCAM and NMDA-NR2B receptor
function in flavonoid-induced spatial memory improvements in young
rats. Neuropharmacology 2014;79:335-44.
Lino MM, Vaillant C, Orolicki S, Sticker M, Kvajo M, Monard D.
Newly generated cells are increased in hippocampus of adult mice
lacking a serine protease inhibitor. BMC Neurosci 2010;11:70.
Lane HY, Lin CH, Green MF, Hellemann G, Huang CC, Chen PW,
et al. Add-on treatment of benzoate for schizophrenia: A randomized,
double-blind, placebo-controlled trial of D-amino acid oxidase
inhibitor. JAMA Psychiatry 2013;70(12):1267-75.
Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y,
Yoshitome E, et al. Negative correlation between brain glutathione
level and negative symptoms in schizophrenia: A 3T 1H-MRS study.
PLoS One 2008;3(4):e1944.
Goff DC, Coyle JT. The emerging role of glutamate in the
pathophysiology and treatment of schizophrenia. Am J Psychiatry
;158(9):1367-77.
Asian J Pharm Clin Res, Vol 9, Issue 4, 2016, 33-36
Nithya and Shanmugarajan
Duncan EJ, Szilagyi S, Schwartz MP, Bugarski-Kirola D, Kunzova A,
Negi S, et al. Effects of D-cycloserine on negative symptoms in
schizophrenia. Schizophr Res 2004;71(2-3):239-48.
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD,
et al. Subanesthetic effects of the noncompetitive NMDA antagonist,
ketamine, in humans. Psychotomimetic, perceptual, cognitive, and
neuroendocrine responses. Arch Gen Psychiatry 1994;51(3):199-214.
Tamminga CA, Holcomb HH, Gao XM, Lahti AC. Glutamate
pharmacology and the treatment of schizophrenia: Current status and
future directions. Int Clin Psychopharmacol 1995;10 Suppl 3:29-37.
Adams BW, Moghaddam B. Effect of clozapine, haloperidol, or
M100907 on phencyclidine-activated glutamate efflux in the prefrontal
cortex. Biol Psychiatry 2001;50(10):750-7.
Singh S, Choudhury A, Gusain P, Parvez S, Palit G, Shukla G, et al.
Oral acetate supplementation attenuates N-methyl D-aspartate receptor
hypofunction-induced behavioral phenotypes accompanied by
restoration of acetyl-histone homeostasis. Psychopharmacology (Berl)
;233:1257-68.
Notarangelo FM, Pocivavsek A. Elevated kynurenine pathway
metabolism during neurodevelopment: Implications for brain and
behavior. Neuropharmacology 2016;pii: S0028-390830073-9.
Lladó-Pelfort L, Troyano-Rodriguez E, van den Munkhof HE, CerveraFerri
A,
Jurado N, Núñez-Calvet M,
et
al.
Phencyclidine-induced
disruption
of
oscillatory
activity
in
prefrontal
cortex:
Effects
of
antipsychotic
drugs
and receptor ligands. Eur Neuropsychopharmacol
;26:614-25.
Rogóz Z, Kaminska K. The effect of combined treatment with
escitalopram and risperidone on the MK-801-induced changes in the
object recognition test in mice. Pharmacol Rep 2016;68(1):116-20.
Boer JA, Westenberg HG, Louwerens JW, Slooff CJ. The clinical
significance of atypical antipsychotics. Acta Neuropsychiatr
;3(4):55-60.
Ihalainen J, Savolainen K, Tanila H, Forsberg MM. Comparison
of phencyclidine-induced spatial learning and memory deficits and
reversal by sertindole and risperidone between Lister Hooded and
Wistar rats. Behav Brain Res 2016;305:140-7.
Lindenmayer JP, Kaur A. Antipsychotic management of schizoaffective
disorder: A review. Drugs 2016;76:589-604.
Amiaz R, Rubinstein K, Czerniak E, Karni Y, Weiser M. A Diet
and fitness program similarly affects weight reduction in
schizophrenia patients treated with typical or atypical medications.
Pharmacopsychiatry 2016.
Fagiolini A, Alfonsi E, Amodeo G, Cenci M, Di Lella M, Farinella F,
et al. Switching long acting antipsychotic medications to aripiprazole
long acting once-a-month: Expert consensus by a panel of Italian and
Spanish psychiatrists. Expert Opin Drug Saf 2016;15:449-55.
Liang HB, Li HH, Hu Y, Li SH, Lü LX, Song XQ. Effects of Topiramate
for atypical antipsychotic-induced body weight gain and metabolic
adversities: A systematic review and meta-analysis. Zhonghua Yi Xue
Za Zhi 2016;96(3):216-23.
Chen Y, Bang S, McMullen MF, Kazi H, Talbot K, Ho MX, et al.
Neuronal activity-induced sterol regulatory element binding protein-1
(SREBP1) is disrupted in dysbindin-null mice-potential link to
cognitive impairment in schizophrenia. Mol Neurobiol 2016.
Tse WS, Wah Wong AS, Chan F, Tat Pang AH, Bond AJ, Chau Kiu
Chan R. Different mechanisms of risperidone result in improved
interpersonal trust, social engagement and cooperative behavior in
patients with schizophrenia compared to trifluoperazine. Psychiatry
Clin Neurosci 2016 11.
Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L,
et al. The G72/G30 gene complex and cognitive abnormalities in
schizophrenia. Neuropsychopharmacology 2006;31(9):2022-32.
Prathikanti S, Weinberger DR. Psychiatric genetics – The new era:
Genetic research and some clinical implications. Br Med Bull 2005;7374:107-22.
Lin CY, Liang SY, Chang YC, Ting SY, Kao CL, Wu YH, et al.
Adjunctive sarcosine plus benzoate improved cognitive function
in chronic schizophrenia patients with constant clinical symptoms:
A randomised, double-blind, placebo-controlled trial. World J Biol
Psychiatry 2015:1-12.
Orozco-Ibarra M, Medina-Campos ON, Sánchez-González DJ,
MartÃnez-MartÃnez CM, Floriano-Sánchez E, SantamarÃa A, et al.
Evaluation of oxidative stress in D-serine induced nephrotoxicity.
Toxicology 2007;229(1-2):123-35.
Maekawa M, Okamura T, Kasai N, Hori Y, Summer KH, Konno R.
D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity.
Chem Res Toxicol 2005;18(11):1678-82.
Williams RE, Lock EA. Sodium benzoate attenuates D-serine induced
nephrotoxicity in the rat. Toxicology 2005;207(1):35-48.
Williams RE, Lock EA. D-serine-induced nephrotoxicity: Possible
interaction with tyrosine metabolism. Toxicology 2004;201(1-3):231-8.
Carone FA, Ganote CE. D-serine nephrotoxicity. The nature of
proteinuria, glucosuria, and aminoaciduria in acute tubular necrosis.
Arch Pathol 1975;99(12):658-62.
Ganote CE, Peterson DR, Carone FA. The nature of D-serine – Induced
nephrotoxicity. Am J Pathol 1974;77(2):269-82.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.